Friday Insider Activity: Top Buys and Sells in US Stocks on Friday

Published 24/02/2025, 15:00
Updated 24/02/2025, 20:39
© Reuters.

This article summarizes the most significant insider buying and selling activities for US stocks reported on Friday.

Top Buys:

CompoSecure, Inc. (NASDAQ:CMPO) saw substantial insider buying activity from multiple parties. Tungsten 2024 LLC, John Cote (director and significant shareholder), and Thomas R. Knott (director and significant shareholder) each purchased 233,070 shares at an average price of $16.57 per share, totaling approximately $3.86 million per transaction. These purchases come as CompoSecure’s stock has delivered an impressive 251% return over the past year and is trading near its 52-week high of $17.71. The company, which specializes in finance services and crypto assets, maintains strong liquidity with a current ratio of 2.43 and has achieved 9.13% revenue growth in the last twelve months.

Solid Biosciences Inc. (NASDAQ:SLDB) received a significant investment from Bain Capital Life Sciences. Through its affiliate BCLS II Investco, LP, Bain Capital acquired 1,000,000 shares at $4.03 per share, totaling $4.03 million. Additionally, they purchased a pre-funded warrant to buy 6,444,170 shares at $4.029 per share. The stock has since surged 43% in the past week to trade at $5.78. Analysts maintain a bullish outlook with price targets ranging from $12 to $28.

TruBridge, Inc. (NASDAQ:TBRG) saw insider buying from two significant shareholders. Pinetree Capital Ltd. and L6 Holdings Inc. collectively purchased shares worth approximately $3.5 million. The insider buying comes as TruBridge shares have surged 183% over the past year, trading near its 52-week high of $29.27.

Top Sells:

Cloudflare, Inc. (NYSE:NET) President and Board Co-Chair Michelle Zatlyn sold shares totaling approximately $13.8 million over a series of transactions. The sales were executed at prices ranging from $156.01 to $167.08 per share as part of a pre-arranged trading plan. Cloudflare maintains impressive gross profit margins of 77% and shows strong revenue growth of 29% in the last twelve months.

Amgen Inc . (NASDAQ:AMGN) saw selling activity from two executives. Esteban Santos, Executive Vice President of Operations, sold shares totaling approximately $2.55 million at an average price of $292.837 each. David M. Reese, Executive Vice President and Chief Technology Officer, sold shares worth approximately $10.2 million in multiple transactions.

Alphabet Inc. (NASDAQ:GOOGL) President and Chief Investment Officer Ruth Porat executed stock sales totaling approximately $3.25 million. The transactions involved Alphabet’s Class C Capital Stock and were conducted at prices ranging from $181.65 to $186.80 per share under a pre-established Rule 10b5-1 trading plan.

Adaptive Biotechnologies Corp (NASDAQ:ADPT) CEO and Chairman Chad M. Robins sold 285,187 shares, generating proceeds of approximately $2.41 million. The sales occurred at prices ranging from $8.44 to $8.46 per share as part of a prearranged trading plan.

Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance. However, it’s important to consider these activities in conjunction with other fundamental and technical analysis factors before making any investment choices.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.